Medical Microinstruments has filed a notice of an exempt offering of securities to raise $110,000,043.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Medical Microinstruments is raising up to $110,000,043.00 in new funding. Sources indicate that as part of senior management President, Mark Toland played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Medical Microinstruments
A developer of novel robotic solutions for unmet medical needs for microsurgery. MMI has developed the first teleoperated robotic platform for suturing in open surgery with wristed microinstruments. It offers the surgeon motion scaling and tremor elimination and aims to facilitate existing procedures as well as enable new ones in the domain of microsurgery, from post-oncological and trauma reconstructions to ophthalmology, organ transplantation and pediatric surgery. The Companys mission is to help more surgeons around the world to offer more advanced procedures, while reducing costs for patients, hospitals and for society at large.
To learn more about Medical Microinstruments, visit http://www.mmimicro.com/
Contact:
Mark Toland, President
763-350-3882
https://www.linkedin.com/in/mark-toland-76970780/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.